Ratings by Goldman Sachs (Andrea Tan)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/27/2022 Insmed INSM New Coverage Buy
(N/A)
23.56
(19.72)
-16.3% Details
4/27/2022 Vor Biopharma, Inc. VOR New Coverage Neutral
(N/A)
5.64
(4.97)
-11.88% Details
2/24/2022 Kodiak Sciences Inc. KOD Maintain Neutral
(N/A)
 
 
  Details
2/11/2022 Codiak Biosciences Inc. CDAK New Coverage Buy
(N/A)
5.34
(2.88)
-46.07% Details
2/11/2022 Kodiak Sciences Inc. KOD New Coverage Neutral
(N/A)
65.23
(7.64)
-88.29% Details
2/11/2022 Centessa Pharmaceuticals CNTA New Coverage Neutral
(N/A)
10.78
(4.87)
-54.82% Details
5/20/2021 Relmada Therapeutics Inc RLMD New Coverage Buy
(N/A)
35.43
(18.99)
-46.4% Details
5/20/2021 Madrigal Pharmaceuticals MDGL New Coverage Buy
(N/A)
133.48
(71.58)
-46.37% Details